Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03354325 · ClinicalTrials.gov registry record · NA
The Bronchiolitis Follow-up Intervention Trial
A NA study of Bronchiolitis, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 304
- Enrollment target
- 4
- Study locations
NCT03354325: Completed NA study of Bronchiolitis, sponsored by University of Utah.
NCT03354325 is a NA study of Bronchiolitis that has completed, run by University of Utah. The registered enrollment target is 304 participants, below the 551-participant average among 12 other Bronchiolitis trials with a reported enrollment target (45% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03354325, a NA study of Bronchiolitis, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 304 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study evaluates the value of routine follow-up with a child's pediatrician after hospitalization for bronchiolitis. Parents of half of participants will be instructed to follow-up with the child's pediatrician regardless of symptom resolution, while the other half will be instructed to follow-up on an as-needed basis (only if the child worsens, doesn't improve, or other concerns develop).
Primary Outcome
Parental anxiety, as measured by the anxiety portion of the Hospital Anxiety and Depression Scale (HADS), a 0-28 point scale, with higher values representing higher anxiety.
Conditions Studied
Interventions
- BEHAVIORAL Scheduled PCP follow-up
- BEHAVIORAL As needed PCP follow-up
Study Locations (4)
California
- Packard El Camino Hospital - Mountain View
- Lucile Packard Children's Hospital - Palo Alto
Utah
- Intermountain Riverton Hospital - Riverton
- Primary Children's Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2019-05-14 |
| Phase | NA |
What the finished NCT03354325 record still lists
NCT03354325 is an interventional study that assigns participants to a tested intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap, below the 551-participant average among 12 other Bronchiolitis trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Bronchiolitis appearing as the primary indexed condition, and to 2 interventions - of which Scheduled PCP follow-up is the first listed.
NCT03354325 reports a single indexed study location in California, Utah.
Frequently Asked Questions
What is clinical trial NCT03354325 about?
NCT03354325 is a clinical study titled "The Bronchiolitis Follow-up Intervention Trial". This study evaluates the value of routine follow-up with a child's pediatrician after hospitalization for bronchiolitis. Parents of half of participants will be instructed to follow-up with the child's pediatrician regardless of symptom resolution, while the other half will be instructed to follow-u...
What is the current status of trial NCT03354325?
This trial is currently completed. It is a NA study. The enrollment target is 304 participants. The study started on 2018-01-01. Estimated completion is 2019-05-14.
What conditions does trial NCT03354325 study?
This clinical trial studies the following conditions: Bronchiolitis.
What interventions are being tested in trial NCT03354325?
The interventions under investigation include: Scheduled PCP follow-up (BEHAVIORAL), As needed PCP follow-up (BEHAVIORAL).
Who is sponsoring clinical trial NCT03354325?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03354325 being conducted?
This trial has 4 study locations across California, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchiolitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03354325's enrollment target sits among peer trials
304 5th of 12 higher than 8 of 12 other Bronchiolitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bronchiolitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Respiratory Support and Treatment for Efficient and Cost-Effective Care
RECRUITING · NA
-
Leveraging Electronic Health Record Tools to Improve the Evidence-Based Treatment of Children Hospitalized With Bronchiolitis
RECRUITING · NA
-
Non-Invasive Ventilation Versus Neurally-Adjusted Ventilatory Assistance (NAVA) for the Treatment of Bronchiolitis
RECRUITING · NA
-
Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children
ACTIVE NOT RECRUITING · NA
-
A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis
COMPLETED · NA
-
Weight-based Flow Rates for Children With Bronchiolitis on High-Flow Nasal Cannula: A Pilot Randomized Control Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
- NCT06096844 · 304 participants · Phase 3
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI